Showing results (111-120 of 492) with videos related to
Sort By:
Pageof 50
Nature Cell Biology|April 13, 2010
Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasisChia-Hsin Chan, Szu-Wei Lee, Chien-Feng Li, et al.Nature|March 19, 2010
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceHui-Kuan Lin, Zhenbang Chen, Guocan Wang, et al.Cell Cycle (Georgetown, Tex.)|January 19, 2005
Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activationShinji Oki, André Limnander, Pin Mei Yao, et al.The Journal of Biological Chemistry|June 18, 2003
The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradationIgal Louria-Hayon, Tamar Grossman, Ronit Vogt Sionov, et al.Biochemical and Biophysical Research Communications|May 4, 2005
Regulation of the p73 protein stability and degradationAndrew Oberst, Mario Rossi, Paolo Salomoni, et al.Neoplasia (New York, N.Y.)|June 22, 2005
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastomaXiaoyi Hu, Pier Paolo Pandolfi, Yi Li, et al.Scientific Reports|August 12, 2017
Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approachKourosh Zarringhalam, Yvonne Tay, Prajna Kulkarni, et al.Cancer Research|June 17, 2005
Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validationAndrew Xiao, Chaoying Yin, Chunyu Yang, et al.Nature|July 12, 2005
Role of nucleophosmin in embryonic development and tumorigenesisSilvia Grisendi, Rosa Bernardi, Marco Rossi, et al.EMBO Molecular Medicine|March 10, 2011
Pml represses tumour progression through inhibition of mTORRosa Bernardi, Antonella Papa, Ainara Egia, et al.Pageof 50